Generic Formulation Products

Finished Dosage Forms - Product List:

Download Brochure

Dr. Reddy’s Laboratories is a leading API supplier, with a presence in over 80 countries and a portfolio of 200+ ANDA filings and approved dossiers. Our offering goes beyond APIs and our global customers have access to high-quality dossiers and finished dosage forms.

Therapy Area

Anti-diabético

Cardiovascular

Sistema nervioso central

Gastro-Intestinal

Otras

Anti-Obesity

Immuno Suppressant

Oncologia

Oncology / Acromegaly

Dosage Form

Oral

Injection

Injectable

Dossier Status

Disponible

Filed

En desarrollo

Therapy Area	Product Name	Strength	Dossier Status
Anti-diabético	Sitagliptin HCL + Metformin	50 + 500, 50 + 850	En desarrollo
Anti-diabético	Sitagliptin Phosphate + Metformin	50 + 500, 50 + 1000 mg	Filed
Anti-diabético	Sitagliptin Phosphate	25, 50 and 100 mg	Filed
Anti-diabético	Sitagliptin HCL	25, 50, 100 mg	Filed
Cardiovascular	Eltrombopag	12.5, 25, 50 and 75 mg	Filed
Cardiovascular	Tafamidis Meglumine	20 mg	En desarrollo
Cardiovascular	Edoxaban	15 mg, 30 mg and 60 mg	En desarrollo
Cardiovascular	Bempedoic acid	120 mg and 240 mg	En desarrollo
Cardiovascular	Bempedoic acid Ezetimibe	180 mg/10 mg	En desarrollo
Oncologia	Olaparib	100 mg and 150 mg	En desarrollo
Oncologia	Fingolimod	0.5 mg	Filed
Oncologia	Bortezomib	3.5 mg	Filed
Oncologia	Bendamustine RTD	45 mg/ml (4 ml) and 25 mg/ml (4 ml)	Filed
Oncologia	Busulfan	6 mg/ml (10 ml)	Filed
Oncologia	Liposomal Doxorubicin	2 mg/ml (10 ml and 25 ml)	Filed
Oncologia	Pazopanib	200 and 400 mg	En desarrollo
Otras	Apremilast	10, 20 and 30 mg	Filed
Otras	Posaconazole	100 mg	Filed
Otras	Naproxen Sodium	275 mg and 550 mg	Filed
Otras	Mesalamine	250 and 500 mg	En desarrollo
Otras	Amphotericin B	50 mg	En desarrollo
Otras	Thiamine	200 mg/2 ml 25's	Filed
Sistema nervioso central	Topiramate ER	25, 50, 100 and 200 mg	Filed
Sistema nervioso central	Edaravone	60 mg/100 ml	Filed
Sistema nervioso central	Dimethyl Fumarate	120 mg and 240 mg	En desarrollo
Sistema nervioso central	Carboprost	USP Inj 250 mcg/ml PFS	Filed
Sistema nervioso central	Colchicine	0.6 mg	Filed
Sistema nervioso central	Vigabatrin	USP 500 mg	Filed

Therapy Area	Product Name	Dosage Form	EU Approval Status	US Approval Status
Oncologia	Everolimus 2.5mg, 5mg & 10mg		Approved	NA
Oncologia	Bortezomib For Injection 3.5 mg/vial	Injection	Approved	Approved

Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.

Product Capabilities

Research and Development	Manufacturing Facilities	Nich Product Opportunities	Vertical Integration
4 State-of-the-art R&D centres in India, U.K., U.S., and Netherlands 1200+ research scientists working on various projects	11 formulations manufacturing facilities	Peptides, Prostaglandins, HPAPIs, Innovative drug delivery, Novel dosage forms, Complex Injectables	More than 60% of our formulations are backward integrated with our In- house API

Our 11 formulations manufacturing facilities that are operated in accordance with cGMP (ICH Q7a) and regularly inspected/audited by international regulatory authorities and customers (USFDA, MHRA, EMA, PMDA, TGA, SAHPRA, ANVISA, Russian MoH, CFDA, COFEPRIS and Health Canada).

Dr. Reddy's has an expertise of developing and manufacturing various dosage forms:

Oral Solids	Injectables	Novel Dosage Forms
Tablets, Chewable tablets, Orodispersible	Lyophilized product and Liquid solution	Emulsions, Suspensions, Microspheres Liposomes tablets, Capsules, soft gel capsules Pellets a and Nanoparticles

Highly experienced and integrated technical team to support from filing-to-launch.
Highly experienced technical and global regulatory teams with experience of 350+ Filings and 150+ approvals across B2B markets.

Regulatory services	Tech Transfer support	Bio Study design support
Team of regulatory experts	Complete knowledge transfer	Clinical pharmacokinetic team available
Support filing activities	Support local manufacturing	Design bio study protocol
Across multiple countries of interest

Global Presence

Meet with our product experts in one-on-one virtual sessions

Our experts will answer your questions, provide advice, and help you understand our product better

Set Up a Meeting

Renuncia

Ninguna información en este sitio web, incluyendo cualquier referencia a cualquier producto o servicio, constituye una oferta de venta ni se interpretará como tal. Los productos protegidos por patentes válidas no se ofrecen ni suministran para uso comercial. Sin embargo, en ciertos casos, a discreción exclusiva de Dr. Reddy's y sujeto a los requisitos legales locales, las cantidades de investigación de dichos productos pueden ofrecerse para fines de presentaciones regulatorias según la Sección 107A de la Ley de Patentes de la India (exención de Bolar), donde existan dichas exenciones regulatorias. Los compradores deben realizar su propia evaluación del producto o servicio, incluyendo el escenario de patentes en sus respectivos mercados, y serán responsables de todas las responsabilidades relacionadas con las patentes. Dr. Reddy's renuncia a todas las garantías, expresas o implícitas, incluyendo, entre otras, las garantías de comerciabilidad, idoneidad para un propósito particular y no infracción.